Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| KCNQ1 | P51787 | Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Atrial fibrillationDeafnessDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| KCNS1 | Q96KK3 | Delayed-rectifier potassium channel regulatory subunit KCNS1 (Delayed-rectifier K(+) channel alpha subunit 1) (Delayed-rectifier potassium channel subunit Kv9.1) (hKv9.1) (Potassium voltage-gated channel modifier subfamily S member 1) | 6 | Fusion and delivery mediation | 1 | 0.53 | ||||
| KCNS3 | Q9BQ31 | Delayed-rectifier potassium channel regulatory subunit KCNS3 (Delayed-rectifier K(+) channel alpha subunit 3) (Delayed-rectifier potassium channel subunit Kv9.3) (Kv9.3) (Potassium voltage-gated channel subfamily S member 3) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediationMetabolism mediation | 1 | 0.53 | |||
| KCNT1 | Q5JUK3 | Potassium channel subfamily T member 1 (KCa4.1) (KNa1.1) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.2) | Disease related genesHuman disease related genesPotential drug targets | 6 | EpilepsyAcute myeloid leukaemiaHodgkin lymphoma | Clinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| KI21B | O75037 | Kinesin-like protein KIF21B | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationImmune mediation | 1 | 0.53 | ||||
| KI26A | Q9ULI4 | Kinesin-like protein KIF26A | Predicted intracellular proteins | Fusion and delivery mediationImmune mediation | 1 | 0.53 | ||||
| KI2S4 | P43632 | Killer cell immunoglobulin-like receptor 2DS4 (CD158 antigen-like family member I) (Natural killer-associated transcript 8) (NKAT-8) (P58 natural killer cell receptor clones CL-39/CL-17) (p58 NK receptor CL-39/CL-17) (CD antigen CD158i) | 1 | Immune mediation | 1 | 0.53 | ||||
| KIF19 | Q2TAC6 | Kinesin-like protein KIF19 | Predicted intracellular proteins | Fusion and delivery mediationImmune mediation | 1 | 0.53 | ||||
| KIT | P10721 | Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117) | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaAlzheimer diseaseBone/articular cartilage neoplasm | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| KLHL5 | Q96PQ7 | Kelch-like protein 5 | Plasma proteinsPredicted intracellular proteins | Immune mediationMetabolism mediation | 1 | 0.53 |